Skip to Content

Notice

Prospective Grant of Start-Up Exclusive Evaluation Option License Agreement: Pre-Clinical Evaluation and Commercial Development of Anti-Tyrosine Kinase-Like Orphan Receptor 1 Antibody-Drug Conjugates for the Treatment of Human Cancers

This document is a correction of an document that was published on 03/23/2015. View Uncorrected Document

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

Correction

In notice document 2015-06486 appearing on pages 15226-15227 in the issue of Monday, March 23, 2015 make the following correction:

On page 15226, in the third column, under the DATES heading, in the last line, “April 6, 2015” should read “April 7, 2015”.

End Preamble

[FR Doc. C1-2015-06486 Filed 3-31-15; 8:45 am]

BILLING CODE 1505-01-P